Curebase Stock
Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.
Sign up today and learn more about Curebase Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Curebase Stock
Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. The company was established in 2017 and is based in San Francisco, California.
Investors
Bold Capital Partners
Liquid 2 Ventures
Whatnot, Cerebral, Newfront Insurance, Swiftly, Mux, Parsley Health, Curebase
Funding History
| August 2018 | $120K |
|---|---|
| October 2018 | $2.5M |
| May 2021 | $15.0M |
Management
Founder & CEO
Tom Lemberg
CTO
Matthew Rials
Investor
Jeff Richards
Vice President Of Business Development
Wayne Bowden
Chief Operating Officer
Storm Stillman
Press
endpts - Aug, 5 2023
Decentralized trials startup Curebase scraps clinical operations business unit, narrows in on software platformindianweb2 - Jan, 24 2023
Prodigi.ai, the AI-powered Digital Diagnostic Platform Acquires Coimbatore-based Data Analytics Platform CubeBaseprnewswire - Jan, 4 2023
Curebase Celebrates Year of Growth, Organizational Maturityprnewswire - Dec, 2 2022
Curebase Partners with Redenlab to Expand Data Capture Capabilities in Pharma Trialsyourstory - Nov, 18 2022
Healthtech startup CureBay raises Rs 50 Cr in Series A round led by Elevar Equityprnewswire - Aug, 23 2022
Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operationsprnewswire - Aug, 16 2022
Curebase Hires Healthcare Attorney Laura Podolsky to Head Legal Teamprnewswire - Aug, 9 2022
Curebase Hires Alan Sun as Vice President of Productprnewswire - Jul, 19 2022
Curebase Releases enhanced Patient App add-on option to all studies to universally better patient participation and choiceprnewswire - Jun, 28 2022
Curebase Hires HR Veteran Andi Seymour as VP of Peoplebiospace - Jun, 8 2022
Curebase, Portamedic Partner to Support Decentralized Clinical Trials with Mobile Phlebotomy Servicesdlvr - May, 22 2022
Curebase and Flow Neuroscience launch clinical trial to test at-home headset for depressionprnewswire - May, 14 2022
Curebase Adds Pharma, Clinical Research Veteran to Advisory Boardstartuparound - May, 6 2022
Curebase thinks the future of clinical testing is decentralized, and raises $40M to prove it – TechCrunchvcnewsdaily - May, 6 2022
Curebase Lands $40M Series B Roundprnewswire - May, 5 2022
Curebase Secures $40 Million in Series B Fundingbiospace - Apr, 22 2022
Curebase selected to launch a clinical investigation of a digital therapeutic for IPFprnewswire - Mar, 15 2022
Curebase Rapidly Reaches Growth Milestonefiercebiotech - Feb, 18 2022
Curebase adds real-world data, AI experts to board in decentralized trial pushprnewswire - Feb, 7 2022
Curebase Joins the SCRS Global Impact Partner Programprnewswire - Dec, 25 2021
Curebase Joins WCG Avoca Quality Consortiummassdevice - Oct, 22 2021
Curebase, Checkable Medical form joint clinical trial to assess at-home strep test kitbiospace - Oct, 6 2021
Curebase, Digital Therapeutics Alliance Announce Partnership to Accelerate Adoption of DTx Productsprnewswire - Sep, 29 2021
Curebase Hires Katri Langel as Senior Director of Program Development for Europeprnewswire - Sep, 9 2021
Curebase Hires Wayne Bowden as Vice President of Business Developmentfiercebiotech - Aug, 27 2021
It's a virtual world: Curebase, AppliedVR team up on virtual reality-based, at-home clinical trialsmobihealthnews - Aug, 26 2021
Curebase teams up with AppliedVR on pain treatment and other digital health dealsbiospace - Aug, 26 2021
Curebase, AppliedVR Announce Agreement to Run Multiple VR Therapy Clinical Trialsprnewswire - Aug, 23 2021
Curebase Secures Jane Myles as Vice President of Clinical Trial Innovationbiospace - Aug, 11 2021
Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Accessprnewswire - Jul, 14 2021
Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platformfiercebiotech - May, 25 2021
Curebase nabs $15M for siteless trials that revolve 'around the patient's lifestyle'zpr - May, 25 2021
Curebase Inks $15M Series A For New Approach To Clinical TrialsTechCrunch - Aug, 22 2018
All 59 startups that launched today at Y Combinator’s S18 Demo Day 2EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
